Isabelle Greiss

ORCID: 0009-0009-0926-0494
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Valve Diseases and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Cardiomyopathy and Myosin Studies
  • Cardiac tumors and thrombi
  • Heart Failure Treatment and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Acute Ischemic Stroke Management
  • Laser Design and Applications
  • Vascular anomalies and interventions
  • Cardiovascular Effects of Exercise
  • Text Readability and Simplification
  • Cardiovascular Syncope and Autonomic Disorders
  • Laser-induced spectroscopy and plasma
  • Cardiovascular Issues in Pregnancy
  • Cardiac Structural Anomalies and Repair
  • ECG Monitoring and Analysis
  • Infective Endocarditis Diagnosis and Management
  • Central Venous Catheters and Hemodialysis
  • Vascular Tumors and Angiosarcomas

Université de Montréal
2019-2024

Centre Hospitalier de l’Université de Montréal
2012-2023

McGill University Health Centre
2016-2020

Montreal Heart Institute
2003-2017

Population Health Research Institute
2017

Centre Hospitalier Universitaire de Sherbrooke
2017

Toronto Public Health
2013

San Raffaele University of Rome
2006

Kyoto first Red Cross hospital
2005

Ratika Parkash George A. Wells Jean L. Rouleau Mario Talajic Vidal Essebag and 95 more Allan C. Skanes Stephen B. Wilton Atul Verma Jeff S. Healey Laurence D. Sterns Matthew T. Bennett Jean-François Roux Léna Rivard Peter Leong‐Sit Mats Jensen‐Urstad Umjeet Jolly François Philippon John L. Sapp Anthony Tang Paul C. MacDonald Matthew T. Bennett Santabhanu Chakrabarti John A. Yeung‐Lai‐Wah Andrew Ignaszewski Stanley Tung Shahnawaz Virani Marc W. Deyell Andrew Krahn Jason G. Andrade Lynn Straatman Mustafa Toma Graham C. Wong Matthew Wei Isabelle Greiss Jean‐Marc Raymond Benoit Coutu Paolo Costi Fadi Mansour Wouter Saint-Phard Isabelle Denis Julie Fleury Jean-François Roux F. Ayala‐Paredes Mariano Badra‐Verdu Charles Dussault Nadia Vachon Véronique Dagenais C. Lamoureux Jeff S. Healey Stuart J. Connolly CS Ribas Syamkumar Divakaramenon Jorge Wong Guy Amit Wendy L. Meyer Isabelle Nault Jean Champagne J. Sarrazin Gilles O’Hara François Philippon L. Blier Benoît Plourde Christian Steinburg Karine Roy Paule Banville Brigitte Ottinger Marie‐Eve Boucher Marina P. Sánchez Léna Rivard Marc Dubuc Peter G. Guerra Katia Dyrda Paul Khairy Laurent Macle Blandine Mondésert Denis Roy Mario Talajic Bernard Thibault Rafik Tadros Véronique Roy Damian Redfearn Hoshiar Abdollah Adrián Baranchuk Kevin Michael Christopher S. Simpson Sharlene Hammond Stephen B. Wilton Brian Clarke Carlos A. Morillo Vikas Kuriachan George D. Veenhuyzen Russell Quinn Derek V. Exner Jonathan G. Howlett Jennifer McKeage Peter Leong‐Sit Lorne J. Gula Allan C. Skanes Jaimie Manlucu Anthony Tang

Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist can be challenging to treat. Pharmacologically based rhythm control of AF has not proven superior rate control. Ablation-based was compared with evaluate if clinical outcomes in patients HF could improved. Methods: This a multicenter, open-label trial blinded outcome evaluation using central adjudication committee. Patients high-burden paroxysmal (>4 episodes 6 months) or persistent (duration <3 years) AF,...

10.1161/circulationaha.121.057095 article EN Circulation 2022-03-22

Background: Radiofrequency catheter ablation for atrial fibrillation has become an important therapy AF; however, recurrence rates remain high. We proposed to determine whether aggressive blood pressure (BP) lowering prevents recurrent (AF) after in patients with AF and a high symptom burden. Methods: randomly assigned 184 BP >130/80 mm Hg (target <120/80 Hg) or standard <140/90 treatment before their scheduled ablation. The primary outcome was symptomatic of AF/atrial...

10.1161/circulationaha.116.026230 article EN Circulation 2017-02-23

Aims Predictors of recurrence following transcatheter cryoablation for atrioventricular nodal reentrant tachycardia (AVNRT) are currently unknown. Our objective was to explore predictors post-cryoablation AVNRT, including the impact procedural endpoints such as complete elimination slow pathway conduction vs. persistent dual (AV) physiology with or without echo beats.

10.1093/europace/eum145 article EN EP Europace 2007-06-08

Background: Cardiac resynchronization therapy (CRT) has been shown to improve symptoms of patients with moderate severe heart failure. Optimal CRT involves biventricular or left ventricular (LV) stimulation alone, atrio‐ventricular (AV) delay optimization, and possibly interventricular timing adjustment. Recently, anodal capture the right ventricle (RV) described for CRT‐pacemakers. It is unknown whether same phenomenon exists in systems associated defibrillators (CRT‐ICD). The RV leads used...

10.1111/j.1540-8159.2005.00158.x article EN Pacing and Clinical Electrophysiology 2005-07-01

Cardiac resynchronization therapy (CRT) is a mainstay in the treatment of heart failure with severe left ventricular dysfunction, especially presence bundle branch block (LBBB). Biventricular pacing demonstrated notable results improving prognosis and quality life these patients1,2, but its implantation strictly dependent on favorable cardiac venous anatomy to allow delivery lead into coronary sinus (CS). Persistent superior vena cava (LSVC) most common congenital thoracic anomaly,...

10.1016/j.hrcr.2024.03.006 article EN cc-by-nc-nd HeartRhythm Case Reports 2024-03-20

Abstract Background Catheter ablation is an established therapy for atrial fibrillation but limited by recurrence; efforts have been made to identify biomarkers that predict recurrence. We investigated the effect of baseline NT-proBNP on AF recurrence following catheter in patients randomized aggressive (< 120/80 mmHg) or standard blood pressure management 140/90 Substrate Modification with Aggressive Blood Pressure Control trial (SMAC-AF). Methods The SMAC-AF study included 173 resistant...

10.1186/s12872-021-02254-5 article EN cc-by BMC Cardiovascular Disorders 2021-09-16

Key Teaching Points•When a pacemaker fails to record ventricular high-rate (VHR) event, true vs functional undersensing should be considered.•True refers failure detect VHR event owing small-amplitude intrinsic signals or the nature of sensing algorithm.•Functional occurs if episode meet definition is not detected as result way in which refractory blanking periods are programmed.•Functional sustained tachycardia can occur with Biotronik pacemakers rate exceeds 240 beats per minute fact that...

10.1016/j.hrcr.2017.11.012 article EN cc-by-nc-nd HeartRhythm Case Reports 2018-02-03
Coming Soon ...